Biomark Diagnostics Inc. — Investor Relations & Filings
Filings indexed
142
across all filing types
Latest filing
2024-04-18
Regulatory Filings
Country
CA
Canada
Listing
CSE
BUX
Biomark Diagnostics Inc. is an oncology-focused company developing advanced liquid biopsy diagnostic technologies for the early detection, monitoring, and screening of cancer. The core technology platform utilizes metabolomics, the study of biomarkers and metabolites, integrated with Artificial Intelligence and Machine Learning algorithms. This approach aims to provide rapid, accurate results for hard-to-detect cancers, thereby improving patient outcomes. The company's pipeline includes the Liquid Biopsy SSAT1 Assay and a Metabolic Panel.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Material change report - English.pdf | 2024-04-18 | English | |
| News release - English.pdf | 2024-04-18 | English | |
| News release - English.pdf | 2024-02-28 | English | |
| News release - English.pdf | 2024-02-26 | English | |
| Report of exempt distribution (45-106F1).pdf | 2024-01-08 | English | |
| Other.pdf | 2023-11-16 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2024
5 filings
| |||||
| 29847880 | Material change report - English.pdf | 2024-04-18 | English | ||
| 29847902 | News release - English.pdf | 2024-04-18 | English | ||
| 29634786 | News release - English.pdf | 2024-02-28 | English | ||
| 29581325 | News release - English.pdf | 2024-02-26 | English | ||
| 29511915 | Report of exempt distribution (45-106F1).pdf | 2024-01-08 | English | ||
|
2023
10 filings
| |||||
| 29490922 | Other.pdf | 2023-11-16 | English | ||
| 29490901 | Management information circular - English.pdf | 2023-11-16 | English | ||
| 29490900 | Form of proxy - English.pdf | 2023-11-16 | English | ||
| 29490898 | Notice of meeting - English.pdf | 2023-11-16 | English | ||
| 29490896 | Other.pdf | 2023-11-16 | English | ||
| 29490894 | Other.pdf | 2023-11-16 | English | ||
| 29494112 | News release - English.pdf | 2023-11-14 | English | ||
| 13690243 | News release - English.pdf | 2023-08-30 | English | ||
| 29137019 | 52-109FV2 - Certification of interim filings - CEO (E).pdf | 2023-08-29 | English | ||
| 29137008 | 52-109FV2 - Certification of interim filings - CFO (E).pdf | 2023-08-29 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova (Taiwan) Corporation
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
Biomark Diagnostics Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/47245/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=47245 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=47245 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=47245 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 47245}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Biomark Diagnostics Inc. (id: 47245)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.